Director, CMC Regulatory Affairs
Company: Larimar Therapeutics
Location: Bala Cynwyd
Posted on: November 2, 2025
|
|
|
Job Description:
Description: About Us: Larimar Therapeutics Inc. is a publicly
held clinical-stage biotechnology company focused on developing
treatments for patients suffering from complex rare diseases using
its novel cell penetrating peptide technology platform. Our lead
product candidate, Nomlabofusp (CTI-1601), is a subcutaneously
administered, recombinant fusion protein intended to deliver human
frataxin (FXN), an essential protein to the mitochondria of
patients with Friedreich’s ataxia. Friedreich’s ataxia is a rare,
progressive, and fatal disease in which patients are unable to
produce sufficient FXN due to a genetic abnormality. We have
assembled an experienced management team, each of whom has over 20
years of pharmaceutical industry experience. Our management team,
employees, and consultants have significant expertise in discovery,
non-clinical and clinical development, regulatory affairs,
manufacturing and CMC. Our company’s strategy is to become a leader
in the treatment of rare diseases by leveraging our
cell-penetrating technology platform and applying our team’s
know-how to the development of Nomlabofusp and our pipeline
projects. We are best characterized by entrepreneurial and
scientific leadership and a participatory workforce committed to
success. If you are searching for a company where urgency, agility,
and commitment to science win the day – we welcome you! Position
Summary: Larimar is seeking a CMC Regulatory Affairs Director to
provide professional experience and leadership supporting the
global CMC regulatory strategy and regulatory activities to bring
products in development through global marketing authorization
approval and launch. The Regulatory Affairs Director will be a key
member of project teams and the role reports to the Regulatory
Affairs Senior Director. Job Duties/Responsibilities: Larimar Team
Membership - The Director of CMC Regulatory Affairs will be a key
member of the regulatory, clinical project, and technical
operations (cross-functional) teams who will manage CMC regulatory
aspects of projects related to global clinical trials, global
health authority interactions and global marketing submissions and
approvals. This person will work independently, and as a member of
a team. - Liaise internally with other members of the Regulatory
Affairs department to coordinate the timely submission of CMC
amendments, discuss suitable CMC strategies, evaluate global
guidances, all to support the development programs of Larimar. -
Works closely with RA Sr. Director and serve as backup to other
global regulatory activities Strategy, Guidance - Responsible for
defining, developing and executing global CMC regulatory strategies
based on knowledge of guidelines with practical experience
(previous IND, CTA, NDA, BLA filings) to successfully achieve
objectives for complex Larimar projects - Provides detailed and
forward-looking tactical advice to technical teams and stakeholders
to achieve timely and efficient program submissions and approval,
while ensuring compliance with applicable global regulatory
requirements - Evaluates proposed manufacturing and quality changes
for impact to current Health Authority Applications (INDs, CTAs)
and provides strategic regulatory guidance for optimal
implementation of changes. CMC Documentation, Submissions and HA
interactions - Develops and manages the content plans for global M3
CMC submissions or responses; coordinates document authoring (new
or update), document review, and finalization of high-quality,
style-guide compliant CMC documents that align with Larimar’s
regulatory submission timing and strategy - With Larimar
organization, manages the CMC portion of Larimar cross-functions
team activity in preparation of meetings with global health
authorities to define meeting objectives, development of meeting
questions, execute the completion of the meeting package content
and ultimate receipt of clear, specific and actional HA feedback
based on the objectives of each meeting. Requirements: Key
Experience, Skills and Knowledge: - Minimum of 4-year undergraduate
degree - 10 years’ experience in a Regulatory Affairs role in the
pharmaceutical industry, experience with Health Canada, EMA, MHRA
and other local European agencies preferred - Understanding of GxP
systems and Quality principles - Ability to research global
regulatory guidance (nonclinical, clinical and CMC) and precedence
to assist in the development and execution of global regulatory
strategies. - Knowledge of eCTD structure, components and basic
regulatory operations which support in-house regulatory submissions
- Experience with preparation (authoring and review) of
high-quality regulatory documents for global Health Authority
submissions including but not limited to IND amendments, CTA
submissions, Global Health Authority Meeting packages and Global
marketing authorization applications. - Excellent communication,
time management and project management skills - Continuous quality
improvement mindset and attention to details - Ability and
willingness to work onsite, while maintaining strong collaboration
in a hybrid work model. - Can do attitude, flexibility, and mental
agility Benefits: Larimar Therapeutics offers all employees a
competitive salary with frequent market benchmarking, incentive
stock options, a comprehensive benefits plan including 401K, and a
flexible PTO policy. We are committed to equal-employment
principles, and we recognize the value of committed employees who
feel they are being treated in an equitable and professional
manner. We strive to find ways to attract, develop and retain the
talent needed to meet business objectives, and to recruit and
employ highly qualified individuals representing the diverse
communities in which we live. Employment policies and decisions on
employment and promotion are based on merit, qualifications,
performance, and business needs. The decisions and criteria
governing the relationship with all candidates and employees are
made in a non-discriminatory manner—without regard to age, race,
color, national origin, gender (including pregnancy, childbirth or
medical condition related to pregnancy or childbirth), gender
identity or expression, religion, physical or mental disability,
medical condition, legally protected genetic information, marital
status, veteran status, military status, sexual orientation, or any
other factor determined to be an unlawful basis for such decisions
by federal, state, or local statutes.
PI54e7cdd71dc0-37156-38807779
Keywords: Larimar Therapeutics, Lower Merion , Director, CMC Regulatory Affairs, Healthcare , Bala Cynwyd, Pennsylvania